Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Current Oncology · 17.04.2026 · 33 (4) · 226
DOI: 10.3390/curroncol33040226 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 17.04.2026. Verfasst von Connie Le und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Division of Radiation Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The advent of immune checkpoint inhibitors has driven progress in hepatocellular carcinoma (HCC) treatment outcomes and enabled opportunities for combining therapeutic modalities. Growing evidence substantiates the utility of radiotherapy, particularly at ablative doses, in the management of HCC. Given the potential for radiotherapy to induce an immunostimulatory environment and potentiate immune checkpoint inhibitor activity, the expanding HCC treatment landscape compels exploration of the combination of radiotherapy and immunotherapy. This review highlights recent advances in the treatment of HCC using radiotherapy and immunotherapy in combination. Radiation can potentiate an anti-tumor response and tumor microenvironment permissive to immunotherapy. Results from randomized clinical trials and retrospective studies consistently show that combinations of radiotherapy and immunotherapy improved the treatment outcomes of unresectable or advanced HCC—especially HCC with macrovascular invasion. Active research to further improve treatment efficacy and reduce side effects is exemplified by more than 20 ongoing clinical trials combining external beam radiotherapy and immunotherapy to treat HCC. Ongoing research aims at prolonging survival and downstaging advanced or unresectable HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Division of Radiation Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
- Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
- Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
- Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada.
ORCID-Profile: Connie Le, Kurian Joseph, Fatimah AlFaraj
Zitieren
APA
Le, C., Abraham, A. G., Tankel, K., Usmani, N., Joseph, K., Severin, D., AlFaraj, F., & Dawson, L. A. (2026). Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma. Current Oncology, 33(4), 226. https://doi.org/10.3390/curroncol33040226
Vancouver
Le C, Abraham AG, Tankel K, Usmani N, Joseph K, Severin D, et al. Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma. Current Oncology. 2026;33(4):226. doi:10.3390/curroncol33040226
BibTeX
@article{Le2026,
author = {Le, Connie and Abraham, Aswin G and Tankel, Keith and Usmani, Nawaid and Joseph, Kurian and Severin, Diane and AlFaraj, Fatimah and Dawson, Laura A},
title = {Combining External Beam Radiotherapy and Immunotherapy for the Treatment of Hepatocellular Carcinoma},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {4},
pages = {226},
doi = {10.3390/curroncol33040226}
}
EUVIMED